Sign In
Buy NBRV
$1.42
+0 (+0%)
At Close: Nov 24, 2023
CONTEPO CRL Is a Blow for Cash-Strapped Nabriva (NBRV), Says Analyst
01:12am, Wednesday, 24'th Jun 2020
The FDA’s equivalent of a red card – a CRL (complete response letter) – got handed out on June 19 to Nabriva Therapeutics (NBRV). Accordingly, the biotech’s share price has dropped nearly 15%
CymaBay Seladelpar Data, And Other News: The Good, Bad And Ugly Of Biopharma
02:32pm, Tuesday, 23'rd Jun 2020
CymaBay posts positive data for seladelpar. Nabriva receives another CRL. Merck reports positive phase 3 data for its pneumonia vaccine.
Is Nabriva Therapeutics plc (NBRV) A Good Stock To Buy?
07:23pm, Monday, 22'nd Jun 2020
We at Insider Monkey have gone over 821 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of Ma
Nabriva Therapeutics Receives Complete Response Letter from FDA on NDA for CONTEPO™ (fosfomycin) for injection
12:52am, Saturday, 20'th Jun 2020
Nabriva Therapeutics plc (NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, announced today that it r
The Daily Biotech Pulse: Tiziana Snags A Patent Win, Decision Day For Nabriva And Evoke, IPOs
11:41am, Friday, 19'th Jun 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 18) * ADC Therapeutics SA (NYSE: ADCT) * Adverum Biotech
Nabriva Therapeutics (NBRV) Catches Eye: Stock Jumps 11.4%
12:39pm, Wednesday, 10'th Jun 2020
Nabriva Therapeutics (NBRV) saw a big move last session, as its shares jumped more than 11% on the day, amid huge volumes.
Nabriva's Shares March Higher, Can It Continue?
11:19am, Monday, 08'th Jun 2020
As of late, it has definitely been a great time to be an investor in Nabriva Therapeutics.
Attention Biotech Investors: Mark Your Calendar For June PDUFA Dates
08:00pm, Monday, 01'st Jun 2020
Despite the FDA tied up with COVID-19-related activities, May turned out to be a positive month for biopharma companies from the perspective of drug approvals. Three new molecular entities were approv
Implied Volatility Surging for Nabriva (NBRV) Stock Options
12:40pm, Monday, 01'st Jun 2020
Investors need to pay close attention to Nabriva (NBRV) stock based on the movements in the options market lately.
Nabriva Therapeutics Announces $38 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
11:31pm, Friday, 29'th May 2020
Nabriva Therapeutics plc (NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, today announced that it h
Nabriva Therapeutics plc (NBRV) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending approv
Nabriva Therapeutics to Present at the Jefferies Virtual Healthcare Conference
08:01pm, Wednesday, 27'th May 2020
Nabriva Therapeutics plc (NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, today announced that Ted
Nabriva Therapeutics plc (NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, announced the publication
Nabriva Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Updates
08:01pm, Monday, 11'th May 2020
-Cash runway extended into the fourth quarter of 2020 through judicious resource management- -XENLETA managed care coverage and patient reimbursement continues to.
Nabriva Therapeutics to Present at the BofA Securities 2020 Virtual Health Care Conference
11:00am, Monday, 11'th May 2020
Nabriva Therapeutics plc (NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, today announced that Ted
